Moderna - Company of interest - lots of cash!!26 Jul 2021 11:00
Moderna back in 2015 when an agreement was struck with Avacta for the use of certain Affimers was not much bigger than Avacta is now. In Feb 2019 when Moderna took the agreement exclusive, they had a market cap of approx 700m. Today their mcap is around the 140bln, with a jaw dropping inflow of cash, for at least the next 2 years. At some point in the near future, we should get an update regarding the progress of their therapeutic target and or progressive milestone payments...or even a request for further Affimers for different targets or more, they are going to be super bullish. Can't wait to see how it develops.
Extract from job add: Carclo Technical Plastics is currently looking for a full-time Material Handler to join our 3rd shift team. The Material Handler is responsible for clean hoppers, grinders, sight glasses, loaders hoses and all material handling equipment. Assure continued operations by providing raw materials, packaging, and components for production equipment and assembly. Support preparation of finished product for shipment of offsite warehouse. Order necessary materials from offsite warehouse. Maintain inventory monitoring along with ensuring stock accuracy. This is a full-time benefits eligible position on 3rd shift. Schedule: 3rd shift: 11:00 PM - 7:00 AM Sunday - Thursday. Requirements
RE: Soros and Gates back buyout of UK diagnostic technology group18 Jul 2021 21:39
Avacta Chairman has history securing major investment from the Gates Foundation.
Dr Forster brings over 25 years of experience in the pharmaceutical and biotechnology industry, most recently leading Immunocore as Chief Executive Officer to become a world-leading immuno-oncology biotech, raising over £230 million in equity and non-dilutive funding as well as securing partnerships with AstraZeneca and the Bill & Melinda Gates Foundation.
Good to see Tucson and Latrobe facilities hiring in USA. Including automated packing technicians, as the chairman stated, tooling contracts are a precursor to manufacturing runs, where revenue and profit are generated. Chairman & CFO buying - also positive signals.
RE: Affimers success in Deepverge wastewater field test24 Jun 2021 07:30
Plus potential news to come on breath test progress.
Ref Avacta RNS 24 September 2020
Avacta Group plc
("Avacta" or "the Group" or "the Company")
Update on Integumen Collaboration
Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to note the update by Integumen plc (AIM: SKIN) ("Integumen") provided today regarding their ongoing development of Affimer-based sensors for the coronavirus in waste water and in human breath.
Dr Alastair Smith, Chief Executive of Avacta Group commented:
"I am very pleased to learn of the promising evaluation of the Affimer reagents in Integumen's sensor systems. Once detailed validation of the sensors has been carried out using SARS-COV-2 virus samples at the University of Aberdeen, and we have reviewed those data, Avacta will provide a further update to the market."
RE: Big trade first thing this morning07 May 2021 03:48
This is the bit in the latest RNS I was thinking about... In relation to CTP... "As previously announced, the division has secured significant new business in the second half of the year mainly related to the medical sector and consisting of both COVID and non-COVID related products. It is particularly pleasing to note that alongside increasing demand from existing customers, the division was also able to secure new customers. As a consequence, tooling orders were particularly strong as the division prepares for volume increases of existing products and the introduction of new ones. A strong focus on cash generation has enabled the division to make significant investments in capital expenditure to support its ability to deliver on anticipated future production contracts without increasing net debt."
In my opinion, this is great news for UK manufacturing, AVCT, ODX, BBI, ABDX, GAD, CAR. AVCT have repeatedly stated that the limiting factor in test production is available manufacturing capacity. The Gov have been listening. This could also help to explain the technical plastics company, Carclo's (CAR) unexpected 15% rise yesterday on no news, they have been strongly linked with the AVCT test over the last 6 months. It is all fitting together nicely. GLA